Evidence map›Paper›PMID 28720149›Full record

ArticleJournal of neuroinflammation2017

Heparanase promotes neuroinflammatory response during subarachnoid hemorrhage in rats.

Benjarat Changyaleket, Zhao Zhong Chong, Randal O Dull, Danop Nanegrungsunk, Haoliang Xu

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Proteoglycans and glycosaminoglycans in central nervous system injury.American journal of physiology. Cell physiology · 2022
    Review
  6. Review
  7. Significance of host heparanase in promoting tumor growth and metastasis.Matrix biology : journal of the International Society for Matrix Biology · 2020
    Article
  8. Article
  9. Heparanase in Acute Kidney Injury.Advances in experimental medicine and biology · 2020
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Benjarat ChangyaleketDepartment of Anesthesiology, University of Illinois at Chicago, Chicago, IL, USA.
Zhao Zhong ChongDepartment of Anesthesiology, University of Illinois at Chicago, Chicago, IL, USA.
Randal O DullDepartment of Anesthesiology, University of Illinois at Chicago, Chicago, IL, USA.
Danop NanegrungsunkDepartment of Anesthesiology, University of Illinois at Chicago, Chicago, IL, USA.
Haoliang XuDepartment of Pathology, University of Illinois at Chicago, 840 South Wood Street, Chicago, IL, 60612, USA. hlxu@uic.edu.ORCID 0000-0002-2022-8964
University of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeparanase, a mammalian endo-β-D-glucoronidase that specifically degrades heparan sulfate, has been implicated in inflammation and ischemic stroke. However, the role of heparanase in neuroinflammatory response in subarachnoid hemorrhage (SAH) has not yet been investigated. This study was designed to examine the association between heparanase expression and neuroinflammation during subarachnoid hemorrhage.

methodsRats were subjected to SAH by endovascular perforation, and the expression of heparanase was determined by Western blot analysis and immunofluorescence in the ipsilateral brain cortex at 24 h post-SAH. Pial venule leukocyte trafficking was monitored by using intravital microscopy through cranial window.

resultsOur results indicated that, compared to their sham-surgical controls, the rats subjected to SAH showed marked elevation of heparanase expression in the ipsilateral brain cortex. The SAH-induced elevation of heparanase was accompanied by increased leukocyte trafficking in pial venules and significant neurological deficiency. Intracerebroventricular application of a selective heparanase inhibitor, OGT2115, which was initiated at 3 h after SAH, significantly suppressed the leukocyte trafficking and improved the neurological function.

conclusionsOur findings indicate that heparanase plays an important role in mediating the neuroinflammatory response after SAH and contributes to SAH-related neurological deficits and early brain injury following SAH.

Indexed as

AnimalsGlucuronidaseHeparanaseInflammationMaleRandom AllocationRatsRats, Sprague-DawleySubarachnoid HemorrhageGlucuronidaseHeparanaseHeparanaseInflammationNeurological functionSubarachnoid hemorrhage

Identifiers

PMID28720149
PMCPMC5516362
OpenAlexW2736892442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.